SCHEMBL10154390

SCHEMBL10154390

CCC(C)(C)c1n[nH]c2ncccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 2/20 0.37
▸ GSK3A P49840 1/20 0.37
▸ GPR84 Q9NQS5 1/20 0.37
▸ MAPT P10636 1/20 0.35
▸ PRKCQ Q04759 2/20 0.35
▸ JAK3 P52333 1/20 0.35
▸ CHRNB2 P17787 1/20 0.35
▸ CHRNA7 P36544 1/20 0.35
▸ CHRNA4 P43681 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ CDC7 O00311 1/20 0.34
▸ ROCK2 O75116 1/20 0.34
▸ MAP4K4 O95819 1/20 0.34
▸ PIM1 P11309 1/20 0.34
▸ PRKACA P17612 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ HIPK2 Q9H2X6 1/20 0.34
▸ CLK4 Q9HAZ1 1/20 0.34
▸ MKNK2 Q9HBH9 1/20 0.34
▸ IRAK4 Q9NWZ3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12689594 0.83 GRM4 (0.39) GSK3BGSK3AGPR84MAPTCDC7
SCHEMBL10154481 0.82 KMT2A (0.38) GSK3BGSK3AGPR84MAPTPRKCQ
SCHEMBL10126673 0.81 GSK3A (0.39) GSK3BGSK3A
SCHEMBL24406204 0.80 MAPT (0.39) GSK3BGSK3AGPR84MAPTPRKCQ
SCHEMBL10126773 0.79 ALDH1A1 (0.41) GSK3BGSK3AMAPTHTT
SCHEMBL1496225 0.76 GRM4 (0.45) GPR84AXLGRM4AURKAPARP1
SCHEMBL31303192 0.76 GRM4 (0.45) GPR84AXLGRM4AURKAPARP1
SCHEMBL13266980 0.75 KDM4E (0.46) GSK3BGSK3AMAPTJAK3CHRNB2
SCHEMBL10154674 0.73 GRM4 (0.43) GSK3BGSK3AGPR84MAPTHTT
SCHEMBL2693851 0.73 GPR84 (0.41) GSK3BGSK3AGPR84MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120016117-A1 INDAZOLEPROPIONIC ACID AMIDE COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-01-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120016117-A1 INDAZOLEPROPIONIC ACID AMIDE COMPOUND SCN9A, SCN1A, SCN1B GSK3B 3552/4885GSK3A 2918/4885GPR84 2155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback